There comes a point where many older adults and their families start to feel healthcare becoming harder to navigate, not easier. Appointments feel short. Questions feel rushed. And it’s not always clear who is actually coordinating everything. At Be Well MD, we hear this often. And it’s exactly why concierge medicine exists here.

For a long time, medicine focused on one goal: helping people live longer.

But today, the conversation sounds different.

More patients are asking a quieter, more personal question. How do I stay myself as I age? Not just longer life, but a life that still feels active, clear, and independent.

High cholesterol, or hypercholesterolemia, often goes unnoticed for years. Most people don’t feel it happening, and that’s what makes research into this condition so important.

Alzheimer’s disease and other forms of dementia change far more than memory. They change daily routines, relationships, independence, and the way families experience time together. For many, it becomes a shared journey.

Respiratory Syncytial Virus (RSV) is a common respiratory virus that most children are exposed to by age two. For many, it looks like a routine cold, but for infants and young children, RSV can sometimes lead to serious breathing complications and hospitalizations.

At Be Well Health, obesity is approached not as a failure of behavior, but as a complex, biologically driven condition… one that demands equally sophisticated, evidence‑based solutions. GLP‑1 research is helping rewrite that story.

COVID-19 hasn’t vanished. In fact, like the flu, COVID-19 continues to mutate, creating new variants that can partially evade immunity and cause reinfection. That means the vaccines we relied on in 2020 or 2021 need regular updates to stay effective against the latest versions of the virus.

At Be Well Health, integrity isn’t just a value we talk about, it’s something we live. It shows up in how we care for one another, how we serve our patients, and how we build trust within the communities we’re honored to support.

Alzheimer’s is a disease for which we currently have no cure. However, we do have treatments that may slow its progression—especially when initiated early. That’s why research like this is so critical.

Caregiving is not easy. It is relentless and often thankless. But it is also powerful. When done well—with resources, yes, but also with heart—it changes lives. It extends them. It improves them. And in many cases, it redeems what we might otherwise consider lost.

While the terms are frequently used interchangeably, the distinction is not just semantic—it has real implications for diagnosis, care, and research. Understanding this difference is vital in helping families navigate care decisions, clinical trials, and support services.

For the first time in over two decades, a breakthrough in pain management has arrived—without the shadow of opioid addiction.

In a world often defined by the rapid pace of modern life and the limits of modern medicine, the story of Stamatis Moraitis offers a compelling story that transcends conventional understanding. 

Oldest Man in U.S. Dies at 110 After Walking Daily and Avoiding Bottled Water — Now Scientists Will Study His Brain (Exclusive story from People Magazine)

Dr. Mark Carlson is featured in an interview on Alzheimer’s Disease. The interview was conducted by Cyndi Cummings, Austin-based expert advocate for seniors.

Can treating hearing loss improve the progression of cognitive function and reduce dementia risk?

While the nationwide "body positivity" movement empowers individuals and boosts confidence, it raises the question of whether we are inadvertently sacrificing our health. Are we justifying obesity?

In a significant stride for global health, the U.S. Food and Drug Administration (FDA) has given its approval to the first-ever vaccine for Respiratory Syncytial Virus (RSV).

New therapies are on the horizon and the future for both treatment and prevention of Alzheimer’s disease looks promising.

One of the key advantages of monoclonal mRNA vaccines is their speed and flexibility. Because they can be designed and produced in a laboratory setting, they can be developed much more quickly than traditional vaccines. This has been demonstrated in the rapid development of mRNA vaccines for COVID-19, with the Pfizer-BioNTech and Moderna vaccines receiving emergency use authorization from the FDA in less than a year from the start of the pandemic.